World Vaccine Congress Europe 2025

Mark J. Newman, PhD Presentation: “Vaccine design to address the immunocompromised: T-lymphocyte driven…Balanced immunity - Broader specificity – Increased memory.” Kelly T. McKee, Jr., MD, MPH Presentation: “Interim Safety and Reactogenicity of GEO-CM04S1, an MVA-vectored, multi-antigen COVID-19 vaccine, in adults with hematologic malignancies receiving cellular therapies.”